In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes

References

1. Baumert T. F., Rogers S. A., Hasegawa K., Liang T. J. 1996; Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98:2268–2276 [View Article][PubMed]
   [Google Scholar]
2. Chan H. L., Thompson A., Martinot-Peignoux M., Piratvisuth T., Cornberg M., Brunetto M. R., Tillmann H. L., Kao J. H., Jia J. D.other authors 2011; Hepatitis B surface antigen quantification: why and how to use it in 2011: a core group report. J Hepatol 55:1121–1131 [View Article][PubMed]
   [Google Scholar]
3. Günther S., Piwon N., Iwanska A., Schilling R., Meisel H., Will H. 1996; Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 70:8318–8331[PubMed]
   [Google Scholar]
4. Kramvis A., Kew M. C. 2005; Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 12:456–464 [View Article][PubMed]
   [Google Scholar]
5. Lin C. L., Kao J. H. 2011; The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 26:Suppl 1123–130 [View Article][PubMed]
   [Google Scholar]
6. Liu C. J., Kao J. H., Chen D. S. 2005; Therapeutic implications of hepatitis B virus genotypes. Liver Int 25:1097–1107 [View Article][PubMed]
   [Google Scholar]
7. Pollicino T., Amaddeo G., Restuccia A., Raffa G., Alibrandi A., Cutroneo G., Favaloro A., Maimone S., Squadrito G., Raimondo G. 2012; Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology 56:434–443 [View Article][PubMed]
   [Google Scholar]
8. Raimondo G., Allain J. P., Brunetto M. R., Buendia M. A., Chen D. S., Colombo M., Craxì A., Donato F., Ferrari C.other authors 2008; Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49:652–657 [View Article][PubMed]
   [Google Scholar]
9. Shi W., Carr M. J., Dunford L., Zhu C., Hall W. W., Higgins D. G. 2012; Identification of novel inter-genotypic recombinants of human hepatitis B viruses by large-scale phylogenetic analysis. Virology 427:51–59 [View Article][PubMed]
   [Google Scholar]
10. Sugiyama M., Tanaka Y., Kato T., Orito E., Ito K., Acharya S. K., Gish R. G., Kramvis A., Shimada T.other authors 2006; Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44:915–924 [View Article][PubMed]
    [Google Scholar]
11. Tacke F., Liedtke C., Bocklage S., Manns M. P., Trautwein C. 2005; CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 54:1309–1317 [View Article][PubMed]
    [Google Scholar]
12. Trinks J., Cuestas M. L., Tanaka Y., Mathet V. L., Minassian M. L., Rivero C. W., Benetucci J. A., Gímenez E. D., Segura M.other authors 2008; Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent. J Viral Hepat 15:827–838[PubMed]
    [Google Scholar]
13. Yuh C. H., Chang Y. L., Ting L. P. 1992; Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66:4073–4084[PubMed]
    [Google Scholar]
14. Zhou B., Wang Z., Yang J., Sun J., Li H., Tanaka Y., Mizokami M., Hou J. 2012; Novel evidence of HBV recombination in family cluster infections in western China. PLoS ONE 7:e38241 [View Article][PubMed]
    [Google Scholar]